XML 16 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation
9 Months Ended
Apr. 28, 2012
Share-Based Compensation

3. Share-Based Compensation

The following table presents share-based compensation expense included in the Company’s consolidated statements of operations (in thousands):

 

     Three Months Ended      Nine Months Ended  
     April 28,
2012
     April 30,
2011
     April 28,
2012
     April 30,
2011
 

Cost of product revenue

   $ 43       $ 32       $ 121       $ 138   

Cost of service revenue

     112         83         345         158   

Research and development

     392         255         1,156         462   

Sales and marketing

     179         185         571         463   

General and administrative

     225         203         679         459   
  

 

 

    

 

 

    

 

 

    

 

 

 

Share-based compensation expense

   $ 951       $ 758       $ 2,872       $ 1,680   
  

 

 

    

 

 

    

 

 

    

 

 

 

Stock option activity under all of the Company’s stock plans since July 31, 2011 is summarized as follows:

 

     Number of
Shares
    Weighted
Average
Exercise

Price
     Weighted
Average
Contractual
Term
(Years)
 

Outstanding at July 31, 2011

     2,993,840      $ 20.33         5.59   

Options granted

     17,875        18.37      

Options exercised

     (140,485     17.40      

Options cancelled

     (482,188     23.99      
  

 

 

      

Outstanding at April 28, 2012

     2,389,042      $ 19.74         6.39   
  

 

 

      

Options vested and expected to vest

     2,350,371      $ 19.73         5.79   

Options exercisable at end of period

     1,650,962      $ 19.46         5.27   

Weighted average fair value of options granted for the nine months ended April 28, 2012

   $ 8.21        

The intrinsic value of options exercised during the nine months ended April 28, 2012 was $0.3 million.

As of April 28, 2012, there was $5.9 million of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Company’s stock plans. That cost is expected to be recognized over a weighted-average period of 1.9 years.